跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avarix 20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avarix 20
Approved
STANDARD
Avarix 20
Healer’s Lab (Unit II)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1afc64a4e0a71129
Company
Healer’s Lab (Unit II)
Type
Standard
Approval Details
Approval Id
1afc64a4e0a71129
Drug Approval Philippines Name
Avarix 20
Product Name
Avarix 20
Registration Number
DRP-13973-01
Brand Name
Avarix 20
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
20 mg
Manufacturer
Healer’s Lab (Unit II)
Importer
Pharmakon Biotec Inc.
Distributor
Teramedix Pharma Trading Inc
Issuance Date
24 August 2024
Expiry Date
26 May 2028
Pharmacologic Category
Lipid Modifying Agent (HMG CoA reductase inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1afc64a4e0a71129
Type
Standard
Back to Philippines FDA Approvals